Detail page

Knowledge Web

Person

Nicola Benjamin (1981-)

Physiotherapeutin

Name	Nicola Benjamin
Time	1981- (Date of birth and death)
Place	Heidelberg (Wirkungsort) Cuxhaven (Geburtsort) Deutschland
Gender	weiblich
Academic degree	Dr. sc. hum. (an der Medizinischen Fakultät Heidelberg der Ruprecht-Karls-Universität) (2023)
Profession	Physiotherapeutin (characteristic profession)
Variant	Nicola Ehlken (früherer Name)
Related	Thoraxklinik Heidelberg Klinikum Heidelberg Lunge (Thema) Biometrie (Thema) Statistik (Thema)
Further information	Studienkoordinatorin, MSc Med. Biometry and Statistics, Thoraxklinik, Universitätsklinikum Heidelberg
Record type	Person
GND-Identifier	1031704345
Record ID	1031704345
Involved in show all Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension Allgemeine Maßnahmen und Management der pulmonalarteriellen Hypertonie Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten? Zusammenfassung und Kommentierung der neuen europäischen Leitlinie zum Lungenhochdruck : Ein Positionspapier von der Arbeitsgemeinschaft PH-DACH und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) Beeinträchtigung der inspiratorischen Muskelfunktion nach COVID-19 Gezielte medikamentöse Therapie der pulmonalarteriellen Hypertonie nach den aktuellen Leitlinien Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients? Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity? Standardisiertes körperliches Training bei Patienten mit pulmonal arterieller Hypertonie und chronisch thromboembolischer pulmonaler Hypertonie ist praktikabel, sicher und effektiv – eine europäische prospektive, multizentrische, randomisierte, kontrollierte Studie Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension Impairment of Inspiratory Muscle Function after COVID-19 Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity? Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension The Experience, Prerequisites, and the Barriers in Organizing a Specialized Rehabilitation Program for Patients with Pulmonary Hypertension Effect of Supervised Training Therapy on Pulmonary Arterial Compliance and Stroke Volume in Severe Pulmonary Arterial Hypertension and Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort Study Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study Survival after Endoscopic Valve Therapy in Patients with Severe Emphysema Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study) Right heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study Subjective evaluation of visual acuity is not reliable to detect disease activity in different exudative maculopathies Reference Ranges and Determinants of Tricuspid Regurgitation Velocity in Healthy Adults Assessed by Two-Dimensional Doppler-Echocardiography Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension EIF2AK4 mutation as “second hit” in hereditary pulmonary arterial hypertension Reference ranges and determinants of right ventricle outflow tract acceleration time in healthy adults by two-dimensional echocardiography Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study Automated 3D Volumetry of the Pulmonary Arteries based on Magnetic Resonance Angiography Has Potential for Predicting Pulmonary Hypertension Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) Exercise training in pulmonary arterial hypertension associated with connective tissue diseases Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Nicola Benjamin (1981-)

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study

Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension

Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial

Oxygenated hemoglobin as prognostic marker among patients with systemic sclerosis screened for pulmonary hypertension

Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study

Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension

Allgemeine Maßnahmen und Management der pulmonalarteriellen Hypertonie

Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?

Zusammenfassung und Kommentierung der neuen europäischen Leitlinie zum Lungenhochdruck : Ein Positionspapier von der Arbeitsgemeinschaft PH-DACH und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)

Beeinträchtigung der inspiratorischen Muskelfunktion nach COVID-19

Gezielte medikamentöse Therapie der pulmonalarteriellen Hypertonie nach den aktuellen Leitlinien

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?

Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?

Standardisiertes körperliches Training bei Patienten mit pulmonal arterieller Hypertonie und chronisch thromboembolischer pulmonaler Hypertonie ist praktikabel, sicher und effektiv – eine europäische prospektive, multizentrische, randomisierte, kontrollierte Studie

Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis

The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review

Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension

Impairment of Inspiratory Muscle Function after COVID-19

Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension

The Experience, Prerequisites, and the Barriers in Organizing a Specialized Rehabilitation Program for Patients with Pulmonary Hypertension

Effect of Supervised Training Therapy on Pulmonary Arterial Compliance and Stroke Volume in Severe Pulmonary Arterial Hypertension and Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension

Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up

Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort Study

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study

Survival after Endoscopic Valve Therapy in Patients with Severe Emphysema

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

Right heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study

Subjective evaluation of visual acuity is not reliable to detect disease activity in different exudative maculopathies

Reference Ranges and Determinants of Tricuspid Regurgitation Velocity in Healthy Adults Assessed by Two-Dimensional Doppler-Echocardiography

Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial Hypertension

Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension

EIF2AK4 mutation as “second hit” in hereditary pulmonary arterial hypertension

Reference ranges and determinants of right ventricle outflow tract acceleration time in healthy adults by two-dimensional echocardiography

Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study

Automated 3D Volumetry of the Pulmonary Arteries based on Magnetic Resonance Angiography Has Potential for Predicting Pulmonary Hypertension

Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial

Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension

Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension

The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR)

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations